Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis

NCT01308021 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

202

Enrollment

INDUSTRY

Sponsor class

Conditions

Grass Pollen Allergy
Hay Fever

Interventions

BIOLOGICAL: gpASIT+TM
BIOLOGICAL: gpASIT+TM
BIOLOGICAL: Placebo

Sponsor

BioTech Tools S.A.